Pfizer Inc recalls Vial Label: 8.4% Sodium Bicarbonate Injection
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Lack of Assurance of Sterility.
- Products
-
- Vial Label: 8.4% Sodium Bicarbonate Injection
- Company
- Pfizer Inc
- Where it was sold
-
U.S. Nationwide
Nationwide
- Units affected
- 15,750 vials
- About this recall
- Vial Label: 8.4% Sodium Bicarbonate Injection, USP, 50mEq/50 mL (1 mEq/mL), Rx only, Hospira, Inc., Lake Forest, IL 60045, USA, NDC 0409-6637-24. Case NDC: 00409-6637-14.